Apellis Pharmaceuticals, Inc. (APLS)
19.94
-0.59
(-2.87%)
USD |
NASDAQ |
Jan 16, 16:00
20.05
+0.11
(+0.55%)
After-Hours: 20:00
Apellis Pharmaceuticals Price: 19.94 for Jan. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amicus Therapeutics, Inc. | 14.33 |
| Alnylam Pharmaceuticals, Inc. | 359.27 |
| Ionis Pharmaceuticals, Inc. | 76.33 |
| Fortress Biotech, Inc. | 3.72 |
| Sarepta Therapeutics, Inc. | 21.13 |
Price Related Metrics
| PE Ratio | 67.14 |
| PS Ratio | 2.482 |
| Price to Book Value | 6.289 |
| Price to Free Cash Flow | 32.08 |
| Earnings Yield | 1.49% |
| Market Cap | 2.523B |
| Operating PE Ratio | 31.38 |
| Normalized PE Ratio | 67.14 |